FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997832483> ?p ?o ?g. }

• W1997832483 endingPage "252" @default.
• W1997832483 startingPage "243" @default.
• W1997832483 abstract "Abstract Treatment for advanced prostate cancer has and will continue to grow increasingly complex, owing to the introduction of multiple new therapeutic approaches with the potential to substantially improve outcomes for this disease. Agents that modulate the patient's immune system to fight prostate cancer – immunotherapeutics – are among the most exciting of these new approaches. The addition of antigen‐specific immunotherapy to the treatment of castration‐resistant prostate cancer ( CRPC ) has paved the way for additional research that seeks to augment the activity of the immune system itself. The monoclonal antibody ipilimumab, approved in over 40 countries to treat advanced melanoma and currently under phase 2 and 3 investigation in prostate cancer, is thought to act by augmenting immune responses to tumors through blockade of cytotoxic T‐lymphocyte antigen 4, an inhibitory immune checkpoint molecule. Ipilimumab has been studied in seven phase 1 and 2 clinical trials that evaluated various doses, schedules, and combinations across the spectrum of patients with advanced prostate cancer. The CRPC studies of ipilimumab to date suggest that the agent is active in prostate cancer as monotherapy or in combination with radiotherapy, docetaxel, or other immunotherapeutics, and that the adverse event profile is as expected given the safety data in advanced melanoma. The ongoing phase 3 program will further characterize the risk/benefit profile of ipilimumab in chemotherapy‐naïve and ‐pretreated CRPC ." @default.
• W1997832483 created "2016-06-24" @default.
• W1997832483 creator A5007578304 @default.
• W1997832483 creator A5034692104 @default.
• W1997832483 date "2013-02-24" @default.
• W1997832483 modified "2023-10-18" @default.
• W1997832483 title "Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?" @default.
• W1997832483 cites W1602314627 @default.
• W1997832483 cites W1977340233 @default.
• W1997832483 cites W1978942158 @default.
• W1997832483 cites W1996445525 @default.
• W1997832483 cites W2049163935 @default.
• W1997832483 cites W2055175265 @default.
• W1997832483 cites W2062135418 @default.
• W1997832483 cites W2068834940 @default.
• W1997832483 cites W2090371822 @default.
• W1997832483 cites W2093424661 @default.
• W1997832483 cites W2095128112 @default.
• W1997832483 cites W2095826876 @default.
• W1997832483 cites W2097995306 @default.
• W1997832483 cites W2103959341 @default.
• W1997832483 cites W2106531781 @default.
• W1997832483 cites W2114040612 @default.
• W1997832483 cites W2117089606 @default.
• W1997832483 cites W2119198740 @default.
• W1997832483 cites W2123363005 @default.
• W1997832483 cites W2132177175 @default.
• W1997832483 cites W2132872147 @default.
• W1997832483 cites W2133123802 @default.
• W1997832483 cites W2138134458 @default.
• W1997832483 cites W2153935963 @default.
• W1997832483 cites W2155846302 @default.
• W1997832483 cites W2155995527 @default.
• W1997832483 cites W2164731084 @default.
• W1997832483 cites W2298617717 @default.
• W1997832483 cites W2562821094 @default.
• W1997832483 cites W3080569900 @default.
• W1997832483 doi "https://doi.org/10.1002/cam4.64" @default.
• W1997832483 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3639663" @default.
• W1997832483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23634292" @default.
• W1997832483 hasPublicationYear "2013" @default.
• W1997832483 type Work @default.
• W1997832483 sameAs 1997832483 @default.
• W1997832483 citedByCount "12" @default.
• W1997832483 countsByYear W19978324832013 @default.
• W1997832483 countsByYear W19978324832014 @default.
• W1997832483 countsByYear W19978324832015 @default.
• W1997832483 countsByYear W19978324832016 @default.
• W1997832483 countsByYear W19978324832017 @default.
• W1997832483 countsByYear W19978324832018 @default.
• W1997832483 countsByYear W19978324832019 @default.
• W1997832483 countsByYear W19978324832020 @default.
• W1997832483 crossrefType "journal-article" @default.
• W1997832483 hasAuthorship W1997832483A5007578304 @default.
• W1997832483 hasAuthorship W1997832483A5034692104 @default.
• W1997832483 hasBestOaLocation W19978324831 @default.
• W1997832483 hasConcept C121608353 @default.
• W1997832483 hasConcept C126322002 @default.
• W1997832483 hasConcept C143998085 @default.
• W1997832483 hasConcept C170493617 @default.
• W1997832483 hasConcept C197934379 @default.
• W1997832483 hasConcept C203014093 @default.
• W1997832483 hasConcept C2777658100 @default.
• W1997832483 hasConcept C2777701055 @default.
• W1997832483 hasConcept C2778468042 @default.
• W1997832483 hasConcept C2780192828 @default.
• W1997832483 hasConcept C2780851360 @default.
• W1997832483 hasConcept C2781190966 @default.
• W1997832483 hasConcept C2781433595 @default.
• W1997832483 hasConcept C502942594 @default.
• W1997832483 hasConcept C71924100 @default.
• W1997832483 hasConcept C8891405 @default.
• W1997832483 hasConceptScore W1997832483C121608353 @default.
• W1997832483 hasConceptScore W1997832483C126322002 @default.
• W1997832483 hasConceptScore W1997832483C143998085 @default.
• W1997832483 hasConceptScore W1997832483C170493617 @default.
• W1997832483 hasConceptScore W1997832483C197934379 @default.
• W1997832483 hasConceptScore W1997832483C203014093 @default.
• W1997832483 hasConceptScore W1997832483C2777658100 @default.
• W1997832483 hasConceptScore W1997832483C2777701055 @default.
• W1997832483 hasConceptScore W1997832483C2778468042 @default.
• W1997832483 hasConceptScore W1997832483C2780192828 @default.
• W1997832483 hasConceptScore W1997832483C2780851360 @default.
• W1997832483 hasConceptScore W1997832483C2781190966 @default.
• W1997832483 hasConceptScore W1997832483C2781433595 @default.
• W1997832483 hasConceptScore W1997832483C502942594 @default.
• W1997832483 hasConceptScore W1997832483C71924100 @default.
• W1997832483 hasConceptScore W1997832483C8891405 @default.
• W1997832483 hasIssue "2" @default.
• W1997832483 hasLocation W19978324831 @default.
• W1997832483 hasLocation W19978324832 @default.
• W1997832483 hasLocation W19978324833 @default.
• W1997832483 hasLocation W19978324834 @default.
• W1997832483 hasLocation W19978324835 @default.
• W1997832483 hasOpenAccess W1997832483 @default.
• W1997832483 hasPrimaryLocation W19978324831 @default.
• W1997832483 hasRelatedWork W2085972006 @default.
• W1997832483 hasRelatedWork W2263980547 @default.

• next